Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy (EDITION III)

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Sanofi

ClinicalTrials.gov Identifier:

NCT01676220

First received: August 28, 2012

Last updated: November 27, 2014

Last verified: November 2014

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2014
Primary Completion Date:	September 2013 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	November 14, 2014